4,7-Bis(5-bromo-4-octylthiophen-2-yl)benzo[c][1,2,5]thiadiazole
- $435 - $679
- Product name: 4,7-Bis(5-bromo-4-octylthiophen-2-yl)benzo[c][1,2,5]thiadiazole
- CAS: 457931-23-6
- MF: C30H38Br2N2S3
- MW: 682.64
- EINECS:
- MDL Number:MFCD28976159
- Synonyms:4,7-Bis(5-bromo-4-octylthiophen-2-yl)benzo[c][1,2,5]thiadiazole;4,7-Bis-(5-bromo-4-octyl-thiophen-2-yl)-benzo[1,2,5]thiadiazole;4,7-Bis(5-bromo-4-n-octyl-2-thienyl)-2,1,3-benzothiadiazole;4-(2-(5-Bromo-4-octyl-thiophen))-7-(2-(4-octylthiophen))-2,1,3-benzothiadiazole;4,7-Bis(5-bromo-4-n-octyl-2-thienyl)-2,1,3-benzothiadiazole;4,7-Bis(5-bromo-4-octylthiophen-2-yl);2,?1,?3-?Benzothiadiazole, 4,?7-?bis(5-?bromo-?4-?octyl-?2-?thienyl)?-;M8052
2 prices
Selected condition:
Brand
- AK Scientific
- TCI Chemical
Package
- 200mg
- ManufacturerAK Scientific
- Product number5325ED
- Product description4,7-Bis(5-bromo-4-octylthiophen-2-yl)-2,1,3-benzothiadiazole
- Packaging200mg
- Price$679
- Updated2021-12-16
- Buy
- ManufacturerTCI Chemical
- Product numberB4684
- Product description4,7-Bis(5-bromo-4-n-octyl-2-thienyl)-2,1,3-benzothiadiazole >97.0%(HPLC)
- Packaging200mg
- Price$435
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 5325ED | 4,7-Bis(5-bromo-4-octylthiophen-2-yl)-2,1,3-benzothiadiazole | 200mg | $679 | 2021-12-16 | Buy |
TCI Chemical | B4684 | 4,7-Bis(5-bromo-4-n-octyl-2-thienyl)-2,1,3-benzothiadiazole >97.0%(HPLC) | 200mg | $435 | 2024-03-01 | Buy |
Properties
Boiling point :661.9±50.0 °C(Predicted)
Density :1.351±0.06 g/cm3(Predicted)
pka :-1.56±0.50(Predicted)
form :powder to crystal
color :Light yellow to Amber to Dark green
CAS DataBase Reference :457931-23-6
Density :1.351±0.06 g/cm3(Predicted)
pka :-1.56±0.50(Predicted)
form :powder to crystal
color :Light yellow to Amber to Dark green
CAS DataBase Reference :457931-23-6
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|